U.S. FDA approves Fennec’s hearing loss therapyFDA/Regulatory, R&D, TherapeuticsThe U.S. Food and Drug Administration has approved Fennec Pharmaceuticals Inc.’s intravenous therapy to prevent chemotherapy-induced hearing loss in children, according to the health regulator’s website. Read more September 21, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/05/FDA-declines-to-authorize-common-antidepressant-as-COVID-treatment-Reuters-5-16-22.jpg 628 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-09-21 11:05:582022-09-21 11:05:58U.S. FDA approves Fennec’s hearing loss therapy